Cell therapy licensing: a web for the unwary in Kimble v. Marvel Entertainment?

Free Editorial by Tania Bubela (Edmonton Clinic Health Academy, AB, Canada) and E Richard Gold (McGill University, QC, Candada) on the balance struck by patent law between innovators and public access to new technologies.

Go to the profile of Regenerative Medicine
Apr 29, 2016
1
0

This free Editorial by Tania Bubela (Edmonton Clinic Health Academy, AB, Canada) and E Richard Gold (McGill University, QC, Candada) discusses some of the challenges new technologies such as gene and cell therapy face around patent law and public access.

Bubela T, Gold ER. Cell therapy licensing: a web for the unwary in Kimble v. Marvel Entertainment? Regen. Med. 11(2), 125–127 (2016). Author for correspondence: tbubela@ualberta.ca.

Do you work in this field? Share your thoughts in the comments section below. You can also find more from this issue here, including lots of free to access content!

Go to the profile of Regenerative Medicine

Regenerative Medicine

Journal, Future Science Group

Regenerative Medicine is an award-winning peer-reviewed journal, in print and web formats. The journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats. Among other indexing services Regenerative Medicine is listed by MEDLINE/Index Medicus, EMBASE/Excerpta Medica, Chemical Abstracts, Science Citation Index Expanded™ (SciSearch®), Emcare, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, Journal Citation Reports/Science Edition®, Scopus® with an Impact Factor of 2.786 (2014). Each issue contains expertly drafted Reviews, Original Research articles, Perspectives, Editorials, topical insight from international leaders in their field, and additional added-value content. The Senior Editor of the journal is Professor Chris Mason, University College London. You can find out more about Regenerative Medicine at our website (www.future-science-group.com/journalprofile/regenerative-medicine/), where you can find the aims and scope of the journal and details of our international editorial board.

No comments yet.